Invesco
VIVO

Invesco’s Meridian Bioscience Inc VIVO Stock Holding History

Invesco’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-264,852
Closed -$8.8M – 4082
2022
Q4 		$8.8M Buy
264,852
+25,895
+11% +$834K ﹤0.01% 1930
2022
Q3 		$7.53M Sell
238,957
-58,339
-20% -$1.89M ﹤0.01% 1974
2022
Q2 		$9.04M Buy
297,296
+62,642
+27% +$1.69M ﹤0.01% 1923
2022
Q1 		$6.09M Sell
234,654
-23,293
-9% -$554K ﹤0.01% 2274
2021
Q4 		$5.26M Sell
257,947
-69,410
-21% -$1.33M ﹤0.01% 2379
2021
Q3 		$6.3M Sell
327,357
-44,915
-12% -$895K ﹤0.01% 2270
2021
Q2 		$8.26M Sell
372,272
-1,692
-0.5% -$35.9K ﹤0.01% 2175
2021
Q1 		$9.82M Sell
373,964
-64,458
-15% -$1.53M ﹤0.01% 1957
2020
Q4 		$8.19M Buy
438,422
+80,638
+23% +$1.51M ﹤0.01% 1913
2020
Q3 		$6.08M Sell
357,784
-200,647
-36% -$3.9M ﹤0.01% 1917
2020
Q2 		$13M Buy
558,431
+191,833
+52% +$2.78M ﹤0.01% 1493
2020
Q1 		$3.08M Buy
366,598
+18,741
+5% +$158K ﹤0.01% 2155
2019
Q4 		$3.4M Sell
347,857
-12,688
-4% -$119K ﹤0.01% 2387
2019
Q3 		$3.42M Sell
360,545
-26,402
-7% -$278K ﹤0.01% 2346
2019
Q2 		$4.6M Sell
386,947
-100,944
-21% -$1.22M ﹤0.01% 2230
2019
Q1 		$8.59M Sell
487,891
-600,904
-55% -$10M ﹤0.01% 1665
2018
Q4 		$18.9M Buy
1,088,795
+413,234
+61% +$7.05M 0.01% 1168
2018
Q3 		$10.1M Buy
675,561
+273,770
+68% +$4.24M ﹤0.01% 1699
2018
Q2 		$6.39M Buy
401,791
+151,679
+61% +$2.26M ﹤0.01% 1989
2018
Q1 		$3.55M Buy
250,112
+48,764
+24% +$722K ﹤0.01% 2169
2017
Q4 		$2.82M Buy
201,348
+11,733
+6% +$172K ﹤0.01% 2347
2017
Q3 		$2.71M Sell
189,615
-895
-0.5% -$12.8K ﹤0.01% 2340
2017
Q2 		$3M Buy
190,510
+12,354
+7% +$178K ﹤0.01% 2259
2017
Q1 		$2.46M Sell
178,156
-308,334
-63% -$4.31M ﹤0.01% 2442
2016
Q4 		$8.61M Buy
486,490
+88,240
+22% +$1.55M ﹤0.01% 1651
2016
Q3 		$7.68M Buy
398,250
+100,650
+34% +$1.97M ﹤0.01% 1676
2016
Q2 		$5.8M Buy
297,600
+45,654
+18% +$895K ﹤0.01% 1814
2016
Q1 		$5.19M Buy
251,946
+74,627
+42% +$1.47M ﹤0.01% 1850
2015
Q4 		$3.64M Buy
177,319
+10,196
+6% +$195K ﹤0.01% 2140
2015
Q3 		$2.86M Buy
167,123
+23,203
+16% +$424K ﹤0.01% 2259
2015
Q2 		$2.68M Buy
143,920
+14,719
+11% +$273K ﹤0.01% 2431
2015
Q1 		$2.46M Buy
129,201
+14,498
+13% +$268K ﹤0.01% 2464
2014
Q4 		$1.89M Sell
114,703
-3,894
-3% -$66.8K ﹤0.01% 2557
2014
Q3 		$2.1M Sell
118,597
-1,235
-1% -$24.3K ﹤0.01% 2500
2014
Q2 		$2.47M Sell
119,832
-18,725
-14% -$385K ﹤0.01% 2439
2014
Q1 		$3.02M Sell
138,557
-936,702
-87% -$21.5M ﹤0.01% 2286
2013
Q4 		$28.5M Sell
1,075,259
-31,392
-3% -$772K 0.01% 1064
2013
Q3 		$26.2M Buy
1,106,651
+61,603
+6% +$1.44M 0.01% 1043
2013
Q2 		$22.5M Buy
+1,045,048
New +$22.5M 0.01% 1057

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Invesco's VIVO Position: Q1 2023 in Review

Invesco sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 264,852 shares — an estimated $8.8M sold.

Invesco first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $28.5M in Q4 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Invesco reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Invesco sold 264,852 Meridian Bioscience Inc shares in Q1 2023, an estimated $8.8M.
  • Invesco first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Invesco's Meridian Bioscience Inc position peaked at $28.5M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Invesco's 13F filing for Q1 2023, filed 12 May 2023.